Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms
…, CB Schechter, B Sigal, MA Stoto, NK Stout… - Annals of internal …, 2009 - acpjournals.org
… Stout, principal investigator); MD Anderson Comprehensive Cancer Center (Dr. Berry,
principal investigator); and Stanford University (Dr. Plevritis, principal investigator). …
principal investigator); and Stanford University (Dr. Plevritis, principal investigator). …
Trends in use of medical imaging in US health care systems and in Ontario, Canada, 2000-2016
Importance Medical imaging increased rapidly from 2000 to 2006, but trends in recent years
have not been analyzed. Objective To evaluate recent trends in medical imaging. Design, …
have not been analyzed. Objective To evaluate recent trends in medical imaging. Design, …
Collaborative modeling of the benefits and harms associated with different US breast cancer screening strategies
JS Mandelblatt, NK Stout, CB Schechter… - Annals of internal …, 2016 - acpjournals.org
… Stout reports grants from the National Cancer Institute during the conduct of the study. Dr.
Schechter reports grants from the National Cancer Institute during the conduct of the study. …
Schechter reports grants from the National Cancer Institute during the conduct of the study. …
Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012
Importance Given recent advances in screening mammography and adjuvant therapy (treatment),
quantifying their separate and combined effects on US breast cancer mortality …
quantifying their separate and combined effects on US breast cancer mortality …
Impact of the COVID-19 pandemic on breast cancer mortality in the US: estimates from collaborative simulation modeling
…, K Kerlikowske, BL Sprague, NK Stout… - JNCI: Journal of the …, 2021 - academic.oup.com
Background The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer
control through short-term declines in screening and delays in diagnosis and treatments. …
control through short-term declines in screening and delays in diagnosis and treatments. …
Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review
Background Metastatic breast cancer (MBC) treatment has changed substantially over time,
but we do not know whether survival post-metastasis has improved at the population level. …
but we do not know whether survival post-metastasis has improved at the population level. …
OR Forum—A POMDP approach to personalize mammography screening decisions
Breast cancer is the most common nonskin cancer and the second leading cause of cancer
death in US women. Although mammography is the most effective modality for breast cancer …
death in US women. Although mammography is the most effective modality for breast cancer …
Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts
BL Sprague, NK Stout, C Schechter… - Annals of internal …, 2015 - acpjournals.org
Background: Many states have laws requiring mammography facilities to tell women with
dense breasts and negative results on screening mammography to discuss supplemental …
dense breasts and negative results on screening mammography to discuss supplemental …
Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16, 18 vaccination
JD Goldhaber-Fiebert, NK Stout… - Journal of the …, 2008 - academic.oup.com
Background The availability of human papillomavirus (HPV) DNA testing and vaccination
against HPV types 16 and 18 (HPV-16,18) motivates questions about the cost-effectiveness of …
against HPV types 16 and 18 (HPV-16,18) motivates questions about the cost-effectiveness of …
Retrospective cost-effectiveness analysis of screening mammography
NK Stout, MA Rosenberg… - Journal of the …, 2006 - academic.oup.com
Background: Many guidelines recommend screening mammography every 1–2 years for
women older than 40 years; more than 70% of women now participate in routine screening. No …
women older than 40 years; more than 70% of women now participate in routine screening. No …